SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 05/30/2024 at 15:01, 2 years 5 months ago

Press Release: Sanofi completes acquisition of Inhibrx, Inc.
Sanofi completes acquisition of Inhibrx, Inc., adding SAR447537 to rare disease pipeline. Former Inhibrx shareholders receive $30.00 per share in cash and one contingent value right. Inhibrx Biosciences begins trading on NASDAQ as INXB

Acquisition Nasdaq Sanofi Inhibrx SAR447537
BRIEF

published on 05/27/2024 at 07:05, 2 years 5 months ago

FDA Grants Priority Review to Sarclisa for Treatment of Multiple Myeloma

FDA Sanofi Multiple Myeloma Sarclisa Chemotherapy
BRIEF

published on 05/21/2024 at 07:35, 2 years 5 months ago

Sanofi, Formation Bio, and OpenAI Announce AI Collaboration

Collaboration AI Drug Development Sanofi OpenAI Formation Bio
PRESS RELEASE

published on 05/21/2024 at 07:30, 2 years 5 months ago

Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
Sanofi, Formation Bio, and OpenAI collaborate to accelerate drug development with AI-powered software. The partnership aims to bring new medicines more efficiently

Collaboration Drug Development Sanofi OpenAI Formation Bio
BRIEF

published on 05/20/2024 at 22:59, 2 years 5 months ago

Sanofi: April 2024 Voting Rights and Shares Information

Voting Rights Shares Financial Disclosure April 2024 Sanofi
PRESS RELEASE

published on 05/20/2024 at 22:54, 2 years 5 months ago

Sanofi: Information concerning the total number of voting rights and shares - April 2024
Sanofi provides total number of issued shares and voting rights as per French Commercial Code and AMF regulations for April 30, 2024

Share Capital Voting Rights French Commercial Code AMF Regulations Sanofi
BRIEF

published on 05/20/2024 at 20:20, 2 years 5 months ago

Dupixent® Reduces COPD Exacerbations in Phase III Study

FDA Clinical Study Inflammation COPD Dupixent
PRESS RELEASE

published on 05/20/2024 at 20:15, 2 years 5 months ago

Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
Late-breaking data from NOTUS confirm Dupixent's effectiveness in reducing COPD exacerbations and improving lung function, presented at ATS and published in NEJM

COPD Dupixent NOTUS Lung Function Exacerbations
BRIEF

published on 05/10/2024 at 08:05, 2 years 5 months ago

Sanofi and Novavax Form Strategic Alliance to Enhance Vaccine Accessibility

COVID-19 Vaccine Vaccine Development Sanofi Novavax Flu Vaccine
PRESS RELEASE

published on 05/10/2024 at 08:00, 2 years 5 months ago

Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
Sanofi and Novavax sign co-exclusive licensing agreement to co-commercialize COVID-19 vaccine & develop flu-COVID-19 combo vaccines. Agreement enhances patient access & protection. Details in press release

COVID-19 Vaccine Licensing Agreement Sanofi Novavax Flu-COVID-19

Published on 10/30/2026 at 23:35, 2 days 7 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 7 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days 9 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 11 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 15 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/02/2026 at 06:00, 43 minutes ago

Wujiang Marks 90 Years Since Fei Xiaotong's Jiangcun Field Study
Published on 11/01/2026 at 10:35, 20 hours 8 minutes ago

Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 1 day 1 hour ago

2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 14 hours ago

SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 2 days 7 hours ago

EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE

View all EQS

Published on 10/30/2026 at 23:00, 2 days 7 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 10 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 12 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 18 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 2 days 21 hours ago

Share buyback

View all LES ECHOS COMFI WIRE

News